Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer

1Oncology Department, Vall d’Hebron University Hospital ‐ Universitat Autonoma de Barcelona (UAB), Barcelona, Spain 2Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain 3Pathology Department, Vall d’Hebron University Hospital ‐ Universitat Autonoma de Barcelona (UAB), Barcelona, Spain 4Pathology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain 5Surgery Department, Vall d’Hebron University Hospital ‐ Universitat Autonoma de Barcelona (UAB), Barcelona, Spain 6Radiotherapy Department, Vall d’Hebron University Hospital ‐ Universitat Autonoma de Barcelona (UAB), Barcelona, Spain 7Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, United States